You are here

  • Home
  • Archive
  • Volume 33, Issue 5
  • The necessity to adhere to evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with ovarian cancer

Article Text

Article menu
Download PDFPDF
Commentary
The necessity to adhere to evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with ovarian cancer

http://dx.doi.org/10.1136/ijgc-2023-004411

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Twitter @donalb5

    • Contributors DJB, WJvD, and OZ contributed equally to this work.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.